Curbstone Financial Management Corp’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Curbstone Financial Management Corp’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,950	Closed	-$442K	–	212
2021 Q4	$442K	Hold	3,950	–	–	0.08%	192
2021 Q3	$497K	Hold	3,950	–	–	0.09%	174
2021 Q2	$535K	Hold	3,950	–	–	0.1%	169
2021 Q1	$536K	Sell	3,950 -600	-13%	-$89.8K	0.11%	162
2020 Q4	$641K	Hold	4,550	–	–	0.13%	141
2020 Q3	$507K	Hold	4,550	–	–	0.12%	152
2020 Q2	$509K	Buy	+4,550	New	+$448K	0.13%	144
2020 Q1	–	Sell	-4,850	Closed	-$461K	–	175
2019 Q4	$461K	Buy	+4,850	New	+$420K	0.11%	168
2019 Q3	–	Sell	-5,050	Closed	-$443K	–	179
2019 Q2	$443K	Sell	5,050 -250	-5%	-$21.3K	0.12%	164
2019 Q1	$480K	Buy	+5,300	New	+$451K	0.13%	156
2018 Q4	–	Sell	-4,600	Closed	-$441K	–	172
2018 Q3	$441K	Hold	4,600	–	–	0.12%	165
2018 Q2	$438K	Hold	4,600	–	–	0.12%	158
2018 Q1	$404K	Buy	+4,600	New	+$420K	0.11%	159

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Curbstone Financial Management Corp's XBI Position: Q1 2022 in Review

Curbstone Financial Management Corp sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2022, closing a stake of 3,950 shares — an estimated $442K sold.

Curbstone Financial Management Corp first reported a position in XBI in Q1 2018 and held it in 13 quarters. The position peaked at $641K in Q4 2020. 702 funds tracked by Wall St. Rank hold XBI as of Q1 2022.

Curbstone Financial Management Corp reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2022 after selling out during the quarter.
Curbstone Financial Management Corp sold 3,950 State Street SPDR S&P Biotech ETF shares in Q1 2022, an estimated $442K.
Curbstone Financial Management Corp first reported a position in State Street SPDR S&P Biotech ETF in Q1 2018 and held it in 13 quarters.
Curbstone Financial Management Corp's State Street SPDR S&P Biotech ETF position peaked at $641K in Q4 2020.
702 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2022.

Based on Curbstone Financial Management Corp's 13F filing for Q1 2022, filed 18 Apr 2022.